OUR VISION IS TO REDUCE ILLNESS AND DEATH ASSOCIATED WITH FUNGAL DISEASES WORLDWIDE.

Epidemiological Studies

The global burden of fungal disease varies substantially by country and by locality within country, as well as by risk group. To gain a full picture of the incidence and prevalence of fungal diseases, as well as trends over time, local, regional and national studies are critical.

In addition to estimating the burden of fungal diseases by country (see published papers here) and 60 country abstracts here:

 

TIMM 2013

Abstracts:  Iran, Mongolia, Zambia, Korea, Jamaica, Trinidad & Tobago, Dominican Republic, Guatemala, Sri Lanka

ECCMID 2013

Abstracts:  Austria,  Brazil,  China, India India Ireland,  Israel, Kenya, Netherlands, Nigeria, Senegal, SingaporeSpain,  Uganda.

ICAAC 2014

Abstracts:  Argentina,  Australia,  Belgium,Mexico, Saudi Arabia, Tanzania

ECCMID, ISHAM and API 2015

Abstracts: Nepal, Thailand, Canada, Ecuador, Chile, Jordan, Egypt, Indonesia, New Zealand

ECCMID 2014

Abstracts: Czech Republic, Denmark, Hungary, Germany, UK, Iraq, Ukraine, Veitnam

AAA 7th and ECCMID 2016

Abstracts: Japan, Bangladesh, Malaysia, Peru, Congo

TIMM 2015

Abstracts: Algeria, France, Greece, Madagascar, Mozambique, Pakistan, Portugal, Serbia, Venezuela

 

GAFFI is promoting several epidemiological studies. These include:

  • Chronic pulmonary aspergillosis after TB
    • Nigeria
    • Kenya
    • Uganda (completed)
    • Indonesia
    • Brazil
  • Cryptococcal pneumonia
    • Indonesia
  • Histoplasma skin test prevalence
    • Nigeria